In late January 2025, Uganda experienced a resurgence of Ebola, specifically the Sudan virus strain, marking the nation’s sixth outbreak of this variant since 2000. The initial case involved a 32-year-old male nurse from Wakiso District, who developed symptoms on January 19 and tragically passed away on January 29 in Kampala District. During his illness, he sought care from a traditional healer in Mbale District and visited multiple health facilities across Wakiso, Mbale, and Kampala Districts.
As of February 11, 2025, the outbreak had resulted in nine confirmed cases, including one death. The remaining eight patients are receiving treatment in Kampala and Mbale, with all in stable condition. To prevent further spread, 265 contacts of the confirmed cases have been quarantined.
In response to the outbreak, Ugandan health authorities, in collaboration with the World Health Organization (WHO), launched a clinical trial for an experimental vaccine targeting the Sudan virus strain. This trial aims to assess the vaccine’s efficacy and safety, marking a significant step in combating this deadly disease.
The Sudan virus strain of Ebola is highly contagious and spreads through contact with bodily fluids of infected individuals. Symptoms include fever, vomiting, and bleeding. The average case fatality rate for Ebola is approximately 50%.
Health officials are closely monitoring the situation, implementing measures to control the outbreak, and providing support to affected communities. The launch of the vaccine trial offers hope for more effective prevention and control strategies in the future.
